No major differences were found when comparing disease groups in total B cells and memory populations, although we did observe a trend toward lower T‐bet+ and CXCR3+ B‐cell frequencies in MS and RDD (Figure 2A,B; Figure S2C,D). The gene discussed is CXCR3; the disease is myeloid sarcoma.